Vincenzo Caruso

Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging

A. Pepe, Antonella Meloni, Marcello Capra et al. · Haematologica · 2010 · 145 citations · Full text

Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy

Alessia Pepe, Antonella Meloni, Giuseppe Rossi et al. · Journal of Cardiovascular Magnetic Resonance · 2013 · 134 citations · Full text

Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach

Alessia Pepe, Antonella Meloni, Giuseppe Rossi et al. · European Heart Journal - Cardiovascular Imaging · 2017 · 114 citations · Full text

Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia

Antonio Piga, Silverio Perrotta, Maria Rita Gamberini et al. · Blood · 2019 · 111 citations · Full text

Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Aurelio Maggio, Angela Vitrano, Marcello Capra et al. · Blood Cells Molecules and Diseases · 2009 · 96 citations

Hematology, Clinical Trials, Italian Society +5